Scott Rocklage is a renowned author, investor and leader in the healthcare industry. He boasts of over 3 decades of experience in the industry. Currently, he works at 5AM Ventures. Scott Rocklage joined the company, as a venture partner, in the year 2003. A year later he was promoted to be a managing partner.
Recently he was interviewed by Ideamensch. His first question was of course how the company came to be. To this he answered that the life science based venture capital was named 5AM because just like 5Am, they were involved early in the formation of the company. Scott Rocklage said that he is successful because of his ability to prioritize, calendar and manage time. He also advised other people to take risk s and venture into entrepreneurship. It is the only way that one can have control over their future and what Scott knows.
Prior to joining AM Ventures, Scott Rocklage had been a number of company, mostly working in leadership positions. He was with Nycomed Salutar Inc., from the year 1990. At Nycomed, he served as the CEO and president of the company, a position that he assumed four years. Two years into working for Nycomed Salutar, he was appointed president, chairman and CEO of Nycomed Interventional INC. He held this position until the year 1994.
In the year 1994, Scott Rocklage co-founded Cubist Pharmaceuticals. He began working for this company as its president. Come the year 2000, he was promoted to serve as the chairman of the board of directors. In the year 2001, he was again promoted to serve as the CEO of the company, a position that he held until the year 2003 and Scott’s lacrosse camp.
In the year 2003, Rocklage joined 5AM. He joined the company as a venture partner. But his experience in the industry led him to being promoted to be a managing partner in the year 2004. He has served as the acting CEO of EPIRUS Biopharmaceuticals from May 6, 2016 to May 11, 2016 when he was appointed as the official CEO of the company.